Real-world study demonstrates promise of genomic profiling for precision treatment

A real-world study has shown that next-generation sequencing (NGS)-based comprehensive genomic profiling (CGP) can be effective in a real-world setting to guide precision neuro-oncology treatment.

Researchers from the University of Hong Kong and Queen Mary Hospital, Hong Kong, and from ACT Genomics in Taipei, Taiwan, Republic of China, set up CGP for 43 patients at a tertiary neuro-oncology center who had either exhausted conventional treatment or required CGP for clinical trials.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.